These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33326735)

  • 1. Intermittent Hypoxia and Its Impact on Nrf2/HIF-1α Expression and ABC Transporters: An in Vitro Human Blood-Brain Barrier Model Study.
    Zolotoff C; Voirin AC; Puech C; Roche F; Perek N
    Cell Physiol Biochem; 2020 Dec; 54(6):1231-1248. PubMed ID: 33326735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sera of elderly obstructive sleep apnea patients alter blood-brain barrier integrity in vitro: a pilot study.
    Voirin AC; Celle S; Perek N; Roche F
    Sci Rep; 2020 Jul; 10(1):11309. PubMed ID: 32647186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline ameliorates hypoxia-induced blood-brain barrier damage by inhibition of HIF-1α through SIRT-3/PHD-2 degradation pathway.
    Yang F; Zhou L; Wang D; Wang Z; Huang QY
    Neuroscience; 2015 Sep; 304():250-9. PubMed ID: 26211444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Blood-Brain Barrier Integrity in an In Vitro Model Subjected to Intermittent Hypoxia: Is Reversion Possible with a HIF-1α Pathway Inhibitor?
    Voirin AC; Chatard M; Briançon-Marjollet A; Pepin JL; Perek N; Roche F
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of HBEC-5i endothelial cell line cultivated in astrocyte conditioned medium as a human blood-brain barrier model for ABC drug transport studies.
    Puech C; Hodin S; Forest V; He Z; Mismetti P; Delavenne X; Perek N
    Int J Pharm; 2018 Nov; 551(1-2):281-289. PubMed ID: 30240829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress.
    Ibbotson K; Yell J; Ronaldson PT
    Fluids Barriers CNS; 2017 Mar; 14(1):6. PubMed ID: 28298215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia increases expression of selected blood-brain barrier transporters GLUT-1, P-gp, SLC7A5 and TFRC, while maintaining barrier integrity, in brain capillary endothelial monolayers.
    Ozgür B; Helms HCC; Tornabene E; Brodin B
    Fluids Barriers CNS; 2022 Jan; 19(1):1. PubMed ID: 34983574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercapnia Exacerbates the Blood-Brain Barrier Disruption Via Promoting HIF-1a Nuclear Translocation in the Astrocytes of the Hippocampus: Implication in Further Cognitive Impairment in Hypoxemic Adult Rats.
    Liu X; Ding H; Li X; Deng Y; Liu X; Wang K; Wen M; Chen S; Jiang W; Zeng H
    Neurochem Res; 2020 Jul; 45(7):1674-1689. PubMed ID: 32328929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydralazine is a Suitable Mimetic Agent of Hypoxia to Study the Impact of Hypoxic Stress on In Vitro Blood-Brain Barrier Model.
    Chatard M; Puech C; Perek N; Roche F
    Cell Physiol Biochem; 2017; 42(4):1592-1602. PubMed ID: 28738383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracellular tightness and the functional expression of efflux transporters P-gp and BCRP in bEnd3 cells.
    Yang S; Jin H; Zhao Z
    Neurol Res; 2018 Aug; 40(8):644-649. PubMed ID: 29683403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Nrf2 signaling mediates hypoglycemia-induced blood-brain barrier endothelial dysfunction in vitro.
    Sajja RK; Green KN; Cucullo L
    PLoS One; 2015; 10(3):e0122358. PubMed ID: 25807533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory stress induced by a combination of cytokines (IL-6, IL-17, TNF-α) leads to a loss of integrity on bEnd.3 endothelial cells in vitro BBB model.
    Voirin AC; Perek N; Roche F
    Brain Res; 2020 Mar; 1730():146647. PubMed ID: 31911168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Increase in Blood-Brain Barrier Permeability in a Murine Model Exposed to Fifteen Days of Intermittent Hypoxia.
    Roche F; Briançon-Marjollet A; Dematteis M; Baldazza M; Gonthier B; Bertholon F; Perek N; Pépin JL
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression.
    Yeh WL; Lu DY; Lin CJ; Liou HC; Fu WM
    Mol Pharmacol; 2007 Aug; 72(2):440-9. PubMed ID: 17513385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intermittent hypoxia with thrombin in an in vitro model of human brain endothelial cells and their impact on PAR-1/PAR-3 cleavage.
    Zolotoff C; Puech C; Roche F; Perek N
    Sci Rep; 2022 Jul; 12(1):12305. PubMed ID: 35853902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
    Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
    Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluation of the hCMEC/D3 based in vitro BBB model for ABC transporter studies.
    Balzer V; Poc P; Puris E; Martin S; Aliasgari M; Auriola S; Fricker G
    Eur J Pharm Biopharm; 2022 Apr; 173():12-21. PubMed ID: 35227855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS.
    Jablonski MR; Jacob DA; Campos C; Miller DS; Maragakis NJ; Pasinelli P; Trotti D
    Neurobiol Dis; 2012 Aug; 47(2):194-200. PubMed ID: 22521463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic Stress Induced by Hydralazine Leads to a Loss of Blood-Brain Barrier Integrity and an Increase in Efflux Transporter Activity.
    Chatard M; Puech C; Roche F; Perek N
    PLoS One; 2016; 11(6):e0158010. PubMed ID: 27337093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models.
    Liu Q; Hou J; Chen X; Liu G; Zhang D; Sun H; Zhang J
    PLoS One; 2014; 9(7):e102442. PubMed ID: 25036090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.